Researchers with the SWOG Cancer Research Network have found that patients with metastatic hormone receptor-positive breast cancer who have low activity levels of the enzyme sTK1 in their blood serum at the start of anti-estrogen ...
Sep 14, 2021
0
6
Brain metastases are a common and dangerous complication in cancer patients. Under the leadership of experts from MedUni Vienna, two of the largest international oncology societies have published new clinical guidelines for ...
Aug 9, 2021
0
2
The first thing to know is: The COVID vaccines are safe, effective, and necessary. Doctors recommend them and the vaccines are available to everyone ages 12 and older in New York state.
Jun 8, 2021
0
7
Researchers from Boston University School of Medicine (BUSM) have identified proteins that are essential for the viability of whole genome doubled tumor cells, yet non-essential to normal cells that comprise the majority ...
Jan 27, 2021
0
37
(HealthDay)—A pair of studies shed new light on why a relatively rare blood cancer—acute myeloid leukemia (AML)—is more deadly among Black patients.
Dec 11, 2020
1
2
A large meta-analysis of breast cancer survivors of childbearing age indicated that they are less likely than the general public to get pregnant, and they face higher risk of certain complications such as preterm labor. However, ...
Dec 9, 2020
0
1
The brain can be affected by a number of different types of tumor and this leads to serious complications such as epileptic attacks, brain edema, hemorrhage, or thrombosis. Hitherto, there have been no uniform standards available ...
Dec 9, 2020
0
13
A new therapy for metastatic colorectal cancer that has been granted fast-track designation by the U.S. Food and Drug Administration is being tested in a phase 3 clinical trial at Vanderbilt-Ingram Cancer Center.
Nov 20, 2020
0
3
Administering radiation therapy to multiple myeloma patients waiting for CAR T cells to be manufactured was found to be safe and undisruptive to CAR T therapy, according to a new study from researchers in the Abramson Cancer ...
Oct 28, 2020
0
1
An international team of researchers has found that selpercatinib, a drug that precisely targets cancers driven by mutations or alterations in the gene RET, was effective at shrinking tumors in patients with nonsmall cell ...
Sep 28, 2020
0
1
